Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell growth on 3D microstructured surfaces.

Materials science & engineering. C, Materials for biological applications·2016
Same author

Population attributable fractions and joint effects of key risk factors for multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Same author

Gold ion implantation into alumina using an "inverted ion source" configuration.

The Review of scientific instruments·2014
Same author

Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially.

Clinical and experimental immunology·2013
Same author

Occupational exposure and risk of central nervous system demyelination.

American journal of epidemiology·2013
Same author

Performance of an inverted ion source.

The Review of scientific instruments·2013

Related Experiment Video

Updated: Jul 5, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Apneusis responding to buspirone in multiple sclerosis.

R J O'Sullivan1, I G Brown, M P Pender

  • 1Department of Neurology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 22, 2008
PubMed
Summary

Apneusis, a prolonged inspiratory effort, is rarely seen in multiple sclerosis (MS). This study reports a case of episodic apneusis in an MS patient that improved with buspirone treatment.

Area of Science:

  • Neurology
  • Respiratory Medicine
  • Neuroimmunology

Background:

  • Apneusis is a rare respiratory disorder characterized by prolonged inspiratory spasms.
  • It typically results from bilateral lesions in the dorsal pons, often due to pontine infarction.
  • Multiple sclerosis (MS) is an infrequently reported cause of apneusis.

Observation:

  • A patient diagnosed with multiple sclerosis (MS) presented with episodic apneusis.
  • The patient's respiratory pattern exhibited prolonged inspiratory efforts characteristic of apneusis.

Findings:

  • The patient's apneusis episodes were episodic in nature.
  • Treatment with buspirone, a selective serotonin type 1A receptor agonist, led to a positive response.

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Behavioral Approaches to Studying Innate Stress in Zebrafish
05:29

Behavioral Approaches to Studying Innate Stress in Zebrafish

Published on: May 1, 2019

Related Experiment Videos

Last Updated: Jul 5, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
13:18

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Behavioral Approaches to Studying Innate Stress in Zebrafish
05:29

Behavioral Approaches to Studying Innate Stress in Zebrafish

Published on: May 1, 2019

Implications:

  • This case suggests a potential therapeutic role for buspirone in managing apneusis associated with MS.
  • Further research may explore the efficacy of serotonin receptor agonists in treating respiratory disturbances in neuroinflammatory conditions.